Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 3/20 | 0.41 |
| ▸ | HRH1 | P35367 | 2/20 | 0.41 |
| ▸ | KIF11 | P52732 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28858586 | 0.93 | MAOA (0.46) | MAOAHTR2AHRH1KIF11CYP3A4 | |
| Carbon Monoxide SCHEMBL10733895 | 0.92 | MAOA (0.38) | MAOAHTR2AHRH1KIF11CYP3A4 | |
| SCHEMBL3325910 | 0.92 | MAOA (0.38) | MAOAHTR2AHRH1KIF11CYP3A4 | |
| Formaldehyde SCHEMBL11357169 | 0.92 | MAOA (0.38) | MAOAHTR2AHRH1KIF11CYP3A4 | |
| SCHEMBL28964148 | 0.91 | MAOA (0.45) | MAOAHTR2AHRH1KIF11CYP3A4 | |
| Carbon Monoxide SCHEMBL11357166 | 0.90 | MAOA (0.36) | MAOAHTR2AHRH1KIF11CYP3A4 | |
| Allylamine SCHEMBL11350886 | 0.88 | MAOA (0.35) | MAOAHTR2AHRH1KIF11CYP3A4 | |
| SCHEMBL474250 | 0.85 | CYP3A4 (0.41) | MAOAHTR2AHRH1KIF11CYP3A4 | |
| SCHEMBL35092 | 0.85 | CYP3A4 (0.45) | CYP3A4TDP1 | |
| SCHEMBL29179 | 0.85 | CYP3A4 (0.45) | CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119928351-B | Nanofiber composite filter material and preparation process | 博裕纤维科技（苏州）有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119928351-A | Nanofiber composite filter material and preparation process | 博裕纤维科技（苏州）有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-20250122269-A1 | SELECTIVE REDUCTION OF ANTIBODIES | ABBVIE INC (US) | 2025-04-17 | — | — | US | claimed |
| CN-119488608-A | Engineering bispecific antibody coupling drug and preparation method and application thereof | 上海药明合联生物技术有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119213022-A | Preparation method of antibody-drug conjugate | 上海迈晋生物医药科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-117838879-B | Preparation method for improving homogeneity of antibody-drug conjugate and application thereof | 上海药明合联生物技术有限公司 | 2024-11-01 | — | — | CN | claimed |
| US-20240216521-A1 | METHODS OF PREPARING CELL-BINDING AGENT-DRUG CONJUGATES | IMMUNOGEN INC (US) | 2024-07-04 | — | — | US | claimed |
| CN-117838879-A | Preparation method for improving homogeneity of antibody-drug conjugate and application thereof | 上海药明合联生物技术有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-113996328-B | Catalyst and application thereof in preparation of geraniol by hydrogenating citral | 万华化学集团营养科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| US-11833214-B2 | Methods of preparing cell-binding agent-drug conjugates | IMMUNOGEN, INC. (US) | 2023-12-05 | — | — | US | claimed |
| WO-2019191630-A1 | SELECTIVE REDUCTION OF ANTIBODIES | ABBVIE INC. (US) | 2019-10-03 | — | — | WO | claimed |
| CN-108150346-B | A kind of anti-icing noise reduction wind electricity blade | 湖南创一新材料有限公司 | 2019-06-14 | — | — | CN | claimed |
| WO-2019016115-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED ARYL KETONES | BASF Agro B.V. (NL) | 2019-01-24 | — | — | WO | claimed |
| CN-106551589-B | A kind of constant temperature drinking device | 嘉兴日昌汽车配件有限公司 | 2018-09-21 | — | — | CN | claimed |
| CN-108204055-A | A kind of energy conservation and environmental protection wall for building | 聂玲 | 2018-06-26 | — | — | CN | claimed |
| CN-105238364-B | Organic high-temperature heat-conductive liquid | 奢派热力科技（上海）有限公司 | 2018-05-25 | — | — | CN | claimed |
| CN-107952484-A | A kind of preparation method and applications with Nafion film supported rare earth metallic catalysts | 江苏大学 | 2018-04-24 | — | — | CN | claimed |
| CN-106551589-A | A kind of constant temperature drinking device | 张有明 | 2017-04-05 | — | — | CN | claimed |
| CN-105238364-A | Organic high temperature thermal conductive liquid | SEAPEC HEATING POWER TECHNOLOGY SHANGHAI CO LTD | 2016-01-13 | — | — | CN | claimed |
| US-7271121-B2 | Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2007-09-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122269-A1 | SELECTIVE REDUCTION OF ANTIBODIES | CD2BP2, CD22, CD2 | MAOA 2555/4885HTR2A 2349/4885HRH1 569/4885 |
| US-11833214-B2 | Methods of preparing cell-binding agent-drug conjugates | EPCAM, CD2BP2, XPA | MAOA 2651/4885HTR2A 3926/4885HRH1 3788/4885 |
| US-20240216521-A1 | METHODS OF PREPARING CELL-BINDING AGENT-DRUG CONJUGATES | EPCAM, CD2BP2, XPA | MAOA 2651/4885HTR2A 3926/4885HRH1 3788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.